CNTA today

$40.50+$0.32 (+0.80%)close Jun 23, 2026

Trend

—

Key levels

Support$40.26

Support$39.16

Centessa Pharmaceuticals plc (CNTA)

$40.50+0.32 (+0.80%)

HOLDGrade: C+Risk: LOW

1D 5D1M1Y 5Y MaxSign up for all timeframes

High40.56

Low40.00

Open40.09

Volume11.04M

Avg Vol1.83M

VWAP40.27

30d High40.50

30d Low39.58

30d Chg+2.30%

See full chart with real-time data

What Is the Price Target for CNTA?

SEPT Low Target

$34.85

SEPT Mid Target

$41.00

SEPT High Target

$47.15

Analyst Consensus

$41.00

Current: $40.50Upside: +1.2%Confidence: 40%Method: Analyst Consensus

Is CNTA a Buy or Sell Right Now?

Investability Score

HOLD12-18 months

Thesis

•Revenue growing 118.9% YoY with UNKNOWN trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CNTA.

Start Free Trial →

Is CNTA Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$35.60

Moat Score

NONE

4/9

Piotroski Score

17.7

Altman Z-Score

What Is Smart Money Doing with CNTA?

Insider Signal

SELLING

0 buys / 8 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

ACCUMULATING

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

Name	Title	Type	Shares	Value	Date
Accardi Mario Alberto	director officer	Sale	604	$24K	May 1, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

CNTA Growth Story

Revenue YoY

118.9%

3yr Revenue CAGR

N/A%

EPS Growth YoY

29.13%

FCF Growth YoY

-36.7%

Revenue Trend

UNKNOWN

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Centessa Pharmaceuticals plc (CNTA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

CNTA — frequently asked questions

What is CNTA stock price today?

Centessa Pharmaceuticals plc (CNTA) is at $40.50, up 0.80% (+$0.32) at the Jun 23, 2026 close.

What is the CNTA price target?

The average analyst price target for CNTA is $41.00, ranging from $40 to $42, based on 2 analysts. Latest: Wells Fargo downgrade on Apr 20, 2026.

What do analysts rate CNTA?

Analyst ratings for CNTA: 0 Buy, 0 Hold, 5 Sell — consensus Sell.

Did CNTA beat earnings?

CNTA last reported on May 5, 2026: EPS -$0.52 vs -$0.38 expected — a miss of 36.8%.

Does CNTA pay a dividend?

CNTA does not currently pay a dividend.

How much debt does CNTA have?

Centessa Pharmaceuticals plc reported $110M of debt and $62M of cash (Mar 31, 2026).

What are CNTA support and resistance levels?

Support: $40.26, $39.16, $30.44.

What are insiders doing with CNTA?

Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.